These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19544357)

  • 1. A disintegrin and metalloprotease 12 (ADAM12) is a prognostic factor in resected pathological stage I lung adenocarcinoma.
    Mino N; Miyahara R; Nakayama E; Takahashi T; Takahashi A; Iwakiri S; Sonobe M; Okubo K; Hirata T; Sehara A; Date H
    J Surg Oncol; 2009 Sep; 100(3):267-72. PubMed ID: 19544357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular profiling of ADAM12 in human bladder cancer.
    Fröhlich C; Albrechtsen R; Dyrskjøt L; Rudkjaer L; Ørntoft TF; Wewer UM
    Clin Cancer Res; 2006 Dec; 12(24):7359-68. PubMed ID: 17189408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC).
    Rocks N; Paulissen G; Quesada Calvo F; Polette M; Gueders M; Munaut C; Foidart JM; Noel A; Birembaut P; Cataldo D
    Br J Cancer; 2006 Mar; 94(5):724-30. PubMed ID: 16495931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated expression of ADAM12 is associated with progression of oral squamous cell carcinoma.
    Uehara E; Shiiba M; Shinozuka K; Saito K; Kouzu Y; Koike H; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Tanzawa H
    Int J Oncol; 2012 May; 40(5):1414-22. PubMed ID: 22267082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of ADAM12 (meltrin alpha) in human giant cell tumours of bone.
    Tian BL; Wen JM; Zhang M; Xie D; Xu RB; Luo CJ
    Mol Pathol; 2002 Dec; 55(6):394-7. PubMed ID: 12456779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
    Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC
    Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization and expression analysis of ADAM12 during chicken embryonic development.
    Lin J; Luo J; Redies C
    Dev Growth Differ; 2010 Dec; 52(9):757-69. PubMed ID: 21158755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the transient receptor potential channel c3 correlates with a favorable prognosis in patients with adenocarcinoma of the lung.
    Saito H; Minamiya Y; Watanabe H; Takahashi N; Ito M; Toda H; Konno H; Mitsui M; Motoyama S; Ogawa J
    Ann Surg Oncol; 2011 Nov; 18(12):3377-83. PubMed ID: 21603869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma.
    Chao YC; Pan SH; Yang SC; Yu SL; Che TF; Lin CW; Tsai MS; Chang GC; Wu CH; Wu YY; Lee YC; Hong TM; Yang PC
    Am J Respir Crit Care Med; 2009 Jan; 179(2):123-33. PubMed ID: 18787218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.
    Carl-McGrath S; Lendeckel U; Ebert M; Roessner A; Röcken C
    Int J Oncol; 2005 Jan; 26(1):17-24. PubMed ID: 15586220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma.
    Shih JY; Tsai MF; Chang TH; Chang YL; Yuan A; Yu CJ; Lin SB; Liou GY; Lee ML; Chen JJ; Hong TM; Yang SC; Su JL; Lee YC; Yang PC
    Clin Cancer Res; 2005 Nov; 11(22):8070-8. PubMed ID: 16299238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of CHRNA1 is associated with reduced survival in early stage lung adenocarcinoma after complete resection.
    Chang PM; Yeh YC; Chen TC; Wu YC; Lu PJ; Cheng HC; Lu HJ; Chen MH; Chou TY; Huang CY
    Ann Surg Oncol; 2013 Oct; 20(11):3648-54. PubMed ID: 23775407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
    Ishikawa M; Miyahara R; Sonobe M; Horiuchi M; Mennju T; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Huang CL; Date H
    Lung Cancer; 2012 Jun; 76(3):431-8. PubMed ID: 22236865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence.
    Shimokawa H; Uramoto H; Onitsuka T; Chundong G; Hanagiri T; Oyama T; Yasumoto K
    J Thorac Cardiovasc Surg; 2011 Apr; 141(4):895-8. PubMed ID: 21093878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma.
    Neri S; Ishii G; Taira T; Hishida T; Yoshida J; Nishimura M; Nagai K; Ochiai A
    Ann Surg Oncol; 2012 Nov; 19(12):3953-62. PubMed ID: 22669451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer.
    Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Baba T; Uramoto H; So T; Yamada S
    Anticancer Res; 2013 May; 33(5):2123-8. PubMed ID: 23645764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer.
    Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Bando T; Date H
    Ann Surg Oncol; 2014 Aug; 21(8):2546-54. PubMed ID: 24633668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
    Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XPC mRNA level may predict relapse in never-smokers with non-small cell lung cancers.
    Yeh KT; Wu YH; Lee MC; Wang L; Li CT; Chen CY; Lee H
    Ann Surg Oncol; 2012 Mar; 19(3):734-42. PubMed ID: 21861227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpressions of RACK1 and CD147 associated with poor prognosis in stage T1 pulmonary adenocarcinoma.
    Zhong X; Li M; Nie B; Wu F; Zhang L; Wang E; Han Y
    Ann Surg Oncol; 2013 Mar; 20(3):1044-52. PubMed ID: 22592183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.